Sort by
Refine Your Search
-
Program Director 360 Huntington Ave, 140 The Fenway R218 Boston, MA 02115 Northeastern University will not provide H-1B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful
-
University will not provide H-1B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position, now or in the future. STEM OPT is not compatible
-
Program Director 360 Huntington Ave, 140 The Fenway R218 Boston, MA 02115 Northeastern University will not provide H-1B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful
-
, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position, now or in the future. STEM OPT is not compatible for this position. The successful applicant
-
Boston, MA 02115 Northeastern University will not provide H-1B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position, now or in the future. STEM OPT
-
Huntington Ave, 140 The Fenway R218 Boston, MA 02115 Northeastern University will not provide H-1B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position
-
Boston, MA 02115 Northeastern University will not provide H-1B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position, now or in the future. STEM OPT
-
, 140 The Fenway R218 Boston, MA 02115 Northeastern University will not provide H-1B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position, now or
-
, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position, now or in the future. STEM OPT is not compatible for this position. The successful applicant
-
indirect/mixed treatment comparisons Health economic models (cost effectiveness analysis and budget impact analysis), and target patient population tools (US intended use and ex-US target patient population